AI in Dental Practices: What Works in 2026

The best starting point is current adoption data rather than vendor marketing. In July 2026, the American Dental Association Health Policy Institute reported that 43.3% of responding dentists were using AI for at least one task in their practices and another 26.4% planned to use it in the future. That does not mean nearly half of practices have automated clinical decision-making. The usage pattern is much more selective.

HPI found that 22.8% of responding dentists used AI for imaging and diagnostics, 13.6% for insurance verification, 13.2% to explain clinical findings, 10.7% for social media, 10.1% for business analytics, and 10.1% for reception or front-desk check-in. Fewer than 5% reported using AI for patient treatment recommendations. The practical signal is clear: dentists are much more comfortable using AI to assist a workflow than to replace the clinician who owns the treatment decision.

Useful dental AI usually has three characteristics. First, it works on a defined task rather than trying to run the entire practice. Second, a staff member or clinician can review what it produced before the output creates a clinical, financial, or patient-facing consequence. Third, the practice can measure whether the tool actually improves speed, consistency, documentation quality, or another workflow metric that matters.

That makes image-analysis assistance, note drafting, charting support, insurance verification, call or message summarization, business analytics, and controlled patient-education drafting more realistic than broad promises of an autonomous dental office. The goal should be augmentation: reduce repetitive work and surface information while keeping a qualified person responsible for interpretation and action.

AI-assisted imaging is one of the most mature dental use cases, but 'AI imaging' is not one interchangeable category. A practice should identify the product's intended use, the images it was designed to analyze, the conditions it is designed to flag, how the output is presented, and what the dentist is expected to do with that output. The U.S. Food and Drug Administration maintains a current list of AI-enabled medical devices authorized for U.S. marketing and explains that listed devices have met applicable premarket requirements for their intended use.

The ADA is also building a standards framework around dental AI. Its current AI standards page highlights ANSI/ADA Standard 1110-1:2025 for validation dataset guidance and ADA Technical Report 1109:2025, which emphasizes independent validation data for AI systems analyzing two-dimensional dental images. For a buyer, that translates into practical questions: What population and image types were used to validate the product? What are its known limitations? How does the vendor describe sensitivity, specificity, and false positives? Can the dentist see the original image and independently reach a conclusion?

An AI overlay should not become the diagnosis by default. Use it as an additional signal, not a substitute for the patient's history, examination, image quality, clinical context, and the dentist's judgment. A useful rollout compares how the tool performs on real practice workflows before it becomes part of routine case presentation or treatment planning.

Documentation assistance is one of the clearest areas of future interest in the ADA data. HPI reported substantial planned adoption for charting and note-taking. That makes sense: dental teams spend time turning clinical conversations, findings, procedures, and follow-up instructions into structured records, and drafting technology can reduce the blank-page burden.

The risk is treating a generated note as if it were a recording of truth. A model can omit a finding, confuse speakers, infer something that was never said, or produce polished language that hides an error. The clinician or authorized staff member should review the final record before it becomes part of the chart. Practices should also define when recordings are created, where audio or transcripts are processed, how long data is retained, who can access it, and what happens when a patient or staff member does not want a conversation captured.

Administrative workflows are attractive because they are repetitive, rules-heavy, and measurable. AI can help summarize payer responses, organize eligibility information, classify incoming messages, draft claim narratives for human review, identify missing fields, summarize calls, and surface patterns in scheduling or collections data. The ADA HPI survey found current and planned interest in insurance verification and other administrative tasks, reinforcing that this is where many dentists expect near-term value.

Keep a clear boundary between assistance and authority. A generated insurance summary should be checked against the payer response. A drafted claim narrative should match the chart. A patient-facing message should not promise coverage, guarantee payment, or create a clinical instruction that no one reviewed. Automation is useful when it reduces keystrokes and search time; it becomes risky when staff stop verifying the source information behind the output.

Hype usually starts when a product is described in terms of broad intelligence instead of a specific workflow. Claims that one system will replace front-desk judgment, autonomously recommend treatment, run patient communications without supervision, or make every part of the practice more efficient should trigger deeper review. The more authority a system receives, the more a practice needs evidence, access controls, monitoring, fallback procedures, and a clear human owner.

Generative AI can also sound more confident than the underlying evidence warrants. A fluent answer is not the same as an accurate answer. Models can produce outdated information, invent references, misunderstand a dental-specific context, or miss a critical exception. For clinical or compliance work, the practice should treat generated text as a draft or research aid until a qualified person verifies it against authoritative information.

A useful rule is to ask what happens when the AI is wrong. If the answer is 'a staff member catches it before anything happens,' the risk may be manageable. If the answer is 'the patient receives a treatment recommendation, the claim goes out, the chart changes, or an administrator account takes action automatically,' the control bar should be much higher.

HIPAA does not create a special category called 'AI data.' The relevant question is what information the tool receives and what the vendor does on behalf of the dental practice. HHS states that a software vendor that needs access to PHI in order to provide its service can be a business associate. HHS also states that a cloud service provider that creates, receives, maintains, or transmits ePHI on behalf of a covered entity is a business associate and requires an appropriate business associate agreement.

That means a dental practice should not paste identifiable patient information into a consumer AI account simply because the interface is convenient. Before an AI tool processes ePHI, determine the vendor relationship, contractual terms, data use, retention, security controls, user access, training-data practices, subcontractors, breach obligations, and whether a BAA is required and available. The tool should also be included in the practice's risk analysis and technology inventory.

A BAA is not a quality seal and does not make the workflow automatically compliant. The practice still needs reasonable and appropriate safeguards, appropriate user access, workforce procedures, device and account security, and a documented understanding of how information moves through the system.

Start with a short acceptable-use policy instead of waiting for every employee to choose their own tools. Define which AI products are approved, whether PHI may be used, which tasks require human review, which outputs may be sent to patients, who can connect an AI tool to email or practice systems, and how new tools are requested. Block or discourage unsanctioned accounts when they create a realistic data-leak path.

NIST's AI Risk Management Framework and its Generative AI Profile provide a useful vocabulary for this work even though they are voluntary and not dental-specific. The core idea is to identify risks, understand the context of use, measure performance and harms, and manage those risks throughout the lifecycle rather than evaluating the tool once at purchase. For a dental office, that means reviewing permissions, data flows, accuracy, vendor changes, incidents, user feedback, and whether the original use case still makes sense.

Pay special attention to tools with connectors or agent-like permissions. An AI assistant that can only draft text has a different risk profile from one that can read email, modify calendars, access cloud files, send patient messages, or act under an administrator account. Grant the minimum access needed for the approved workflow and keep logs where the platform supports them.

South Florida practices often combine bilingual patient communication, high use of digital imaging and scanners, multiple software vendors, and owners who operate more than one location. AI can help with translation drafts, call summaries, patient education, reporting, or documentation, but those workflows should preserve review by staff who understand the patient, the language, and the clinical context. Machine translation should not silently become the final clinical instruction when nuance matters.

Multi-location groups should also avoid letting each office adopt separate AI products without governance. Standardize approved tools, identity and access controls, vendor review, retention rules, and support ownership across locations. A consistent policy makes it easier to onboard staff, remove access when roles change, investigate an incident, and understand where patient information may be processed.

Days 1-30: inventory AI already in use, including features embedded inside imaging, practice-management, phone, marketing, and productivity products. Identify which tools receive patient or business-sensitive information, which accounts are personal versus practice-managed, and which workflows already depend on generated output. Stop obvious unsanctioned PHI use and document approved use cases.

Days 31-60: choose one or two narrow pilots with clear owners and success measures. Examples include a documentation assistant with required clinician review, an imaging-assistance feature used within its intended purpose, or an administrative summarization workflow that never sends output without staff approval. Review vendor security, contractual terms, BAA requirements, permissions, retention, and fallback procedures before the pilot expands.

Days 61-90: evaluate whether the pilot actually saves time or improves consistency without creating new errors or support burden. Document the result, train users, remove unnecessary permissions, define monitoring, and decide whether to expand, revise, or stop. The best AI roadmap is not the one with the most tools. It is the one where every tool has a defined purpose, an accountable owner, protected data flows, and a human who knows when not to trust the output.